^18F-FDG PET/CT and contrast-enhanced CT in the diagnosis of Castleman disease

[1]  T. Werner,et al.  Emerging role of 18F-FDG PET/CT in Castleman disease: a review , 2021, Insights into Imaging.

[2]  S. Jung,et al.  FDG PET/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings , 2020, Diagnostics.

[3]  Zhouyang Lian,et al.  Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients , 2020, EJNMMI Research.

[4]  A. Dispenzieri,et al.  Overview of Castleman Disease. , 2020, Blood.

[5]  Shuang Zhao,et al.  Imaging and clinical features of Castleman Disease , 2019, Cancer Imaging.

[6]  R. Floris,et al.  Multicentric Castleman's disease: Report of three cases , 2018, Radiology case reports.

[7]  J. Rossi,et al.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. , 2018, Blood.

[8]  D. Simpson.  Epidemiology of Castleman Disease. , 2018, Hematology/oncology clinics of North America.

[9]  L. Vercellino,et al.  The full spectrum of Castleman disease: 273 patients studied over 20 years , 2018, British journal of haematology.

[10]  N. Aide,et al.  Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  M. Haap,et al.  Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides. , 2017, Blood reviews.

[12]  J. Galvin,et al.  Castleman Disease of the Thorax: Clinical, Radiologic, and Pathologic Correlation: From the Radiologic Pathology Archives. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  N. Munshi,et al.  Use of a claims database to characterize and estimate the incidence rate for Castleman disease , 2015, Leukemia & lymphoma.

[14]  N. Munshi,et al.  Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients. , 2015, The British journal of radiology.

[15]  D. Weisenburger,et al.  The clinical spectrum of Castleman's disease , 2012, American journal of hematology.

[16]  K. Horton,et al.  Castleman disease: the great mimic. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[17]  Xiang-yang Liu,et al.  A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients , 2010, Medical oncology.

[18]  M. O'Doherty,et al.  FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  Michel Meignan,et al.  Report on the First International Workshop on interim-PET scan in lymphoma , 2009, Leukemia & lymphoma.

[20]  M. Bower,et al.  Fifty years of multicentric Castleman's disease , 2004, Acta oncologica.

[21]  B. Bader-Meunier,et al.  Paediatric Castleman disease: report of seven cases and review of the literature , 1999, European Journal of Pediatrics.

[22]  F. Jacobson,et al.  The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management. , 2012, European journal of radiology.

[23]  J. Hatazawa,et al.  Unicentric and multicentric Castleman's disease. , 2007, The British journal of radiology.